Back to Market Feed

PHENTERMINE 37.5 MG TABLET

Phentermine Hydrochloride

$0.0694per EA

DEA Schedule CIV

Strength

37.5 mg/1

Manufacturer

Elite Laboratories, Inc.

NDC

64850081001

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

PHENTERMINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

On Market Since

5/1/2014

Pharmacological Classes

Appetite Suppression

Increased Sympathetic Activity

Sympathomimetic Amine Anorectic

Price History

1W

0.0%

1M

-0.2%

3M

-1.0%

6M

+3.7%

1Y

-12.4%

3Y

N/A

5Y

N/A

All

-23.3%

Generic Alternatives

7 alternatives • Same active ingredient

PHENTERMINE 37.5 MG TABLET

68094070270•Precision Dose Inc.

PHENTERMINE 37.5 MG TABLET

64850081010•Elite Laboratories, Inc.

PHENTERMINE 37.5 MG TABLET

10702002501•KVK-Tech Inc.

PHENTERMINE 37.5 MG TABLET

43547040410•Solco Healthcare US LLC

PHENTERMINE 37.5 MG TABLET

53489067610•Sun Pharmaceutical Industries Inc.

PHENTERMINE 37.5 MG TABLET

51224010150•TAGI Pharma Inc.

PHENTERMINE 37.5 MG TABLET

13107006101•Aurolife Pharma LLC

Related Drugs

Same classification

NASAL SPRAY 0.05%

36800030410•Topco Associates LLC

NASAL SPRAY 0.05%

36800081710•Topco Associates LLC

NASAL DECONGESTANT 0.05% SPRAY

51672203005•Taro Pharmaceuticals U.S.A. Inc.

NASAL DECONGESTANT 0.05% SPRAY

51672203003•Taro Pharmaceuticals U.S.A. Inc.

PHENTERMINE 37.5 MG TABLET

11534016001•Sunrise Pharmaceutical Inc.

PHENTERMINE 37.5 MG TABLET

11534016003•Sunrise Pharmaceutical Inc.

PHENTERMINE 37.5 MG TABLET

11534016030•Sunrise Pharmaceutical Inc.

GS SINUS NASAL SPRAY 0.05%

00113081710•L. Perrigo Company

NASAL DECONGESTANT 0.05% SPRAY

00904676130•Major Pharmaceuticals

GS NASAL SPRAY 0.05%

00113030410•L. Perrigo Company